BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Alexion Pharmaceuticals Incorporated

Alexion Pharmaceuticals Incorporated is a biopharmaceutical company engaged in the research and development of proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company is developing C5 Complement Inhibitors and Apogens, two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.


Contact Details:
352 Knotter Drive
Cheshire
06410
United States of America
Tel:203 272 2596
Fax:203 772 3655
Email:alexion.europe@alxn.com
WWW:

www.alexionpharm.com/




Recent Publications by Alexion Pharmaceuticals Incorporated:

C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients.
We explored whether a functionally blocking anti-C5 monoclonal antibody...
4th July, 2008
Alexion Pharmaceuticals, Inc., Cheshire, CT, USA. Am J Transplant. 2008 Jun;8(6):1129-42. Epub 2008 Apr 29.
DOI Direct Link
Characterization of cartilage from H-transferase transgenic pigs.
Cartilage engineering is the object of intense research as a result of...
25th June, 2008
Department of Molecular Sciences, Alexion Pharmaceuticals, Inc, Cheshire, Transplant Proc. 2008 Mar;40(2):554-6.
DOI Direct Link
Mass spectrometry and HPLC with fluorescent detection-based orthogonal approaches to characterize N-linked oligosaccharides of recombinant monoclonal antibodies.
A number of HPLC and mass spectrometric techniques are used to...
5th June, 2008
Alexion Pharmaceuticals, Cheshire, CT, USA. Methods Mol Biol. 2008;446:347-61.
DOI Direct Link
Comparability and monitoring immunogenic N-linked oligosaccharides from recombinant monoclonal antibodies from two different cell lines using HPLC with fluorescence detection and mass spectrometry.
One of the most important structural features of recombinant monoclonal...
5th June, 2008
Alexion Pharmaceuticals, Cheshire, CT, USA. Methods Mol Biol. 2008;446:333-46.
DOI Direct Link
Monitoring glycosylation of therapeutic glycoproteins for consistency by HPLC using highly fluorescent anthranilic acid (AA) tag.
Majority of protein drugs in development today are glycoproteins e.g....
5th June, 2008
Alexion Pharmaceuticals, Cheshire, CT, USA. Methods Mol Biol. 2008;446:317-31.
DOI Direct Link

View more Alexion Pharmaceuticals Incorporated research publications.

BioNews Results for Alexion Pharmaceuticals Incorporated:

Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
KRON4:  Oct 4 2008 6:17AM Matching: alexion pharmaceuticals
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
KSLA:  Oct 4 2008 12:09AM Matching: alexion pharmaceuticals
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
Montana's News Station:  Oct 3 2008 4:45PM Matching: alexion pharmaceuticals
Alexion's Soliris receives 'Nobel' equivalent
Checkbiotech:  Oct 2 2008 4:00PM Matching: alexion pharmaceuticals
A Top BioMarin Drug Heads Overseas
Checkbiotech:  Oct 1 2008 3:12PM Matching: alexion pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Alexion Pharmaceuticals Incorporated news.

Alexion Pharmaceuticals Incorporated Patents:

US Patent No.Title
7427665 Chronic lymphocytic leukemia cell line
6355245 C5-specific antibodies for the treatment of inflammatory diseases
6338820 Apparatus for performing assays at reaction sites
6074642 Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
6040428 Porcine E-selectin

View more Alexion Pharmaceuticals Incorporated patents.

Alexion Pharmaceuticals Incorporated (ALXN) Financial information Links from Barchart

ALXN Quote from from Barchart.com
ALXN Chart from from Barchart.com
ALXN Profile from from Barchart.com
ALXN Opinion from from Barchart.com

View more Alexion Pharmaceuticals Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 14 individuals from Alexion Pharmaceuticals Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 296 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: alexion pharmaceuticals contacts | Alexion Pharmaceuticals | Alexion pharmaceuticals xenotransplantation | alexion pharmaceuticals address | alexion | VECTOR AND PHARMACEUTICALS | ALEXION | .

Search for more companies in Cheshire

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Alexion Pharmaceuticals Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.